Skip to content

Computed Tomography (CT) Guided Lung Biopsy With Plug

Computed Tomography (CT) Guided Lung Biopsy With Plug - Evaluation of Safety and Efficacy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03526640
Enrollment
560
Registered
2018-05-16
Start date
2018-05-04
Completion date
2023-08-04
Last updated
2018-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Computed Tomography, Biopsy, Pneumothorax, Chest Tube, Plug

Brief summary

Protocol Title: Computed Tomography (CT) Guided Lung Biopsy with BioSentry Plug, Evaluation of Safety and Efficacy.

Detailed description

Protocol Summary: Prospective, randomized, controlled, unblinded, post-market, single-center clinical study Objectives: Patients treated with the BioSentry system will be compared to patients not treated with the BioSentry System (Control Group). Primary Objective: Evaluate the rate of chest tube placement after percutaneous transthoracic needle lung biopsy Secondary Objectives: Evaluate the rate of intra-procedural pneumothorax Evaluate the rate of post-procedural pneumothorax Evaluate cost associated with complications Evaluate the number of hospital admissions

Interventions

DEVICEThe BioSentry Tract Sealant System

The BioSentry Tract Sealant System consists of a delivery system and a coaxial adapter with Bio-Seal™ plug. The hydrogel plug is deployed in the tract created by the lung biopsy needle and self-expands upon contact with moist tissue.

Sponsors

University Hospital, Akershus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Block randomized design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Provide written informed consent prior to any study related procedure 2. Male or female, aged ≥18 years or older 3. Percutaneous transthoracic needle lung biopsy indicated

Exclusion criteria

There are no specific

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the rate of chest tube2 yearsEvaluate the rate of chest tube placement after percutaneous transthoracic needle lung biopsy

Countries

Norway

Contacts

Primary ContactHaseem Ashraf, Associate professor, PhD
ashr@ahus.no0047 67964572

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026